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Abstract
Background and Significance: Deaths related to opioid overdose are increasing.
Treatment for opioid use disorder (OUD) is necessary to help prevent future
opioid abuse, and often involves opioid detoxification, followed by short-term
residential treatment, typically lasting about 28 days. Literature regarding OUD
and short-term residential treatment is limited. The purpose of this study was to
determine predictors of short-term residential OUD treatment completion, and
whether detoxification prior to entering residential treatment predicts residential
treatment completion.
Method: De-identified data regarding detoxification and short-term residential
treatment was obtained from a Texas substance abuse treatment center. A set
of predictors from three domains of interest were assessed: demographics, social
factors, and drug history factors. Chi-square and Mann-Whitney U tests for
categorical and continuous variables, respectively, were used to examine
associations between independent variables and residential treatment
completion. The same tests were run between the primary independent variable
of detoxification prior to residential treatment and the other independent
variables. Variables statistically significant for short-term residential completion
and the primary independent variables were entered into binomial logistic
regression models, assessing odds ratios of potential predictors of residential
treatment completion.
Results: Of the total sample of 1001 patients, males were more likely to
complete short-term residential treatment in both detoxification models tested
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(p = .001). Full-time employment was 2.132 times more predictive of residential
completion than was unemployment (p = .049). Those reporting inhaled opioid
abuse were 2.342 times more likely to complete short-term residential treatment
than those who injected opioids (p = .022). Detoxification prior to residential
treatment did not predict residential completion (Adjusted odds ratio = 1.302, p =
.123). For every day spent in detoxification, one was less likely to complete
residential treatment (aOR = .960, p = .032). Medicaid participants were less
likely than those in a state-sponsored program to complete residential treatment
in both detoxification models (p = .019 and p = .013).
Conclusion: Health providers can reinforce that detoxification is not a cure for
OUD, but a beginning of recovery. The use of medication-assisted treatment
programs may be one option to improve treatment completion.

Key words: Opioid Use Disorder; Detoxification; Residential Treatment
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Summary of Study
The proposal for this study was approved November 21, 2018, by the
University of Texas Health Science Center at Houston. Proposed demographics
of interest were age, sex, race, level of education, area of residence, length of
stay in treatment. Proposed social factors included legal problems, living
situation, and employment. Drug history data was to include opioid of choice,
route of drug administration, length of drug use, age of first use, as well as
history of prior treatments. Comorbid medical and psychiatric diagnoses were
also proposed for examination. Data regarding detoxification will be examined,
to include length of detoxification, number of prior detoxifications, and specific
opioid(s) of abuse. Detoxification as a predictor of short-term residential
treatment completion was also to be examined.
Data regarding detoxification was to be examined, to include length of
detoxification, number of prior detoxifications, and specific opioid(s) of abuse.
Detoxification as a predictor of short-term residential treatment completion will
also be examined.
Modifications to the final study were necessitated due extensive
missingness in the data set provided. Specifically, no data was available
regarding education, medical diagnoses, or psychiatric diagnoses (other than
opioid use disorder diagnoses). Data on living situations was also not available.
Large amounts of missing data prevented using the variables of martial status
and legal classification into the final regression equations.
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Proposal Abstract
In 2014, mortality from drug overdose surpassed motor vehicle accidents as
the number one cause of accidental death in the United States (Rudd, Aleshire,
Zibbell, & Gladden, 2016). The current opioid epidemic has contributed to this
new statistic. Treatment opioid use disorder (OUD) is necessary to decrease
further morbidity and mortality.
Treatment for OUD often includes residential treatment centers (RTC) for the
patient, consisting approximately 30 days. Treatment may include initial
detoxification, coupled with counseling and other forms of therapy (Substance
Abuse and Mental Health Services Administration, 2017). The purpose of this
study is to determine predictors for completing residential treatment for OUD, and
whether detoxification prior to entering RTC may also be factor in completing
RTC. The specific aims of this project include:
1: To examine if demographics, social factors, drug history, and co-morbid
diagnosis predict completion of a short-term residential treatment center;
2: To investigate if there is a relationship between undergoing detoxification
or not prior to entry into RTC that predicts completion of short-term residential
treatment, and answer the hypothesis that necessity for OUD detoxification prior
to RTC entry will predict poor RTC completion.
Data from an RTC program in Texas (four different sites in total) will be
examined. Predictors of completion of RTC will be examined, including
demographics, drug history, social factors, and co-morbidities. Logistic
regression will be used to examine whether these factors help predict RTC
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completion. Data from the corresponding detoxification centers at the four sites
will be examined and compared to RTC completion to determine if there is a
difference between those undergoing detoxification prior to RTC entry and those
entering RTC directly.
The significance of this project will help to provide further evidence for OUD
for those in residential treatment. This study is innovative in that it seeks to
examine predictors of RTC completion with and without prior detoxification, which
may result in a clinical paradigm shift, as more specific interventions can be
tailored to those with OUD.
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Specific Aims
In 2014, mortality from drug overdose surpassed motor vehicle accidents as
the number one cause of accidental death in the United States (Rudd, Aleshire,
Zibbell, & Gladden, 2016). The current opioid epidemic has contributed to this
new statistic. Treatment is key for those who are addicted to opioids.
Treatment for OUD often involves residential or inpatient treatment. Shortterm residential treatment centers (RTC) typically includes a patient residing in
the RTC community for about 30 days (SAMHSA, 2017). Frequently treatment
includes medically supervised detoxification coupled with counseling and an
introduction to social support groups, such as Alcoholics Anonymous and
Narcotics Anonymous. Treatment may also consist of medication-assisted
treatment, (MAT) (SAMHSA, 2016).
Several studies have been conducted examining drop-out from different
treatment modalities, such as detoxification only, long-term therapeutic
communities, and outpatient therapies (Brorson, Arnevik, Rand-Hendriksen, &
Duckert, 2013). However, few studies have examined predictors of completion in
short-term treatment, representing a gap in the literature. Therefore, there is a
critical need to understand these predictors in order to develop interventions for
this population. The overall objective of this study is to determine predictors for
completing RTC and to answer the question of what variables are related to
completion of RTC among adult OUD patients that undergo medical
detoxification prior to entering RTC and those not requiring detoxification upon
RTC entry?
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The specific aims of this project are:
1: To examine if demographics, social factors, drug history, and co-morbid
diagnosis predict completion of a short-term residential treatment center.
The hypothesis is that demographics, social factors, drug history, and comorbid diagnosis predict completion of a short-term residential treatment
center.
- determining predictors of completion will provide data for providers that will
assist to further tailor the treatment program to the individual.
2: To investigate if there is a relationship between undergoing detoxification or
not prior to entry into RTC that predicts completion of short-term
residential treatment. The hypothesis is that those who undergo OUD
detoxification prior to RTC entry are less likely to complete short-term
residential treatment than those who do not undergo OUD detoxification.
-determining whether undergoing detoxification for OUD helps or hinders
one’s chances of completing residential treatment may help further tailor
the treatment program to the individual.
This study is innovative in its approach in that it seeks to examine RTC
completion for OUD and whether detoxification prior to RTC is a disadvantage for
completing short-term residential treatment.
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Significance
Overdose mortality is on the rise. Death from heroin, synthetic opioids,
cocaine and benzodiazepines overdoses have each increased (NIDA, 2017a;
NIDA 2017b). About 2.5 million visits to the emergency department involved
drug or alcohol abuse or misuse (Substance Abuse and Mental Health Services
Administration [SAMHSA], 2013).
Mortality from drug overdose (OD) has been increasing, particularly among
opioid abusers. Mortality from OD has increased from 2005 to 2015, from 29,813
to 52,404 (NIDA, 2017a). Heroin has seen a steep increase in OD deaths from
just over 2,000 in 2010 to 15,446 deaths in 2016, equating to a six-fold increase
over six years. Synthetic opioids like fentanyl (other than methadone) have seen
an even greater spike in OD deaths: 2013 witnessed around 3,000 deaths and
over 20,000 in 2016 (NIDA, 2017b). Treatment for OUD is necessary to help
prevent relapse to opioid use and continued addiction to opioids, which in turn
should help to decrease the number of opioid overdoses.
Medically-Supervised Opioid Detoxification
Detoxification for opioid dependence often may be the first step in seeking
treatment. Medically-supervised detoxification typically includes the patient
remaining in an inpatient facility and being monitored while the symptoms of
withdrawal from the opioid are managed pharmacologically. The patient may
also undergo individual and group therapy during this phase of treatment.
Buprenorphine is an opioid receptor partial-agonist often used for
dextoxification and maintenance of OUD recovery. It has a strong affinity for
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these receptors, making it difficult to be removed by other powerful opioid
agonists such as heroin. Buprenorphine is available in a single-drug sublingual
tablet or, as a sublingual tablet or strip combined with the opioid antagonist,
naloxone. The naloxone portion acts as a prevention for abuse of the
medication. When taken sublingually, buprenorphine is able to provide its opioid
effects, as naloxone does not work well when taken sublingually. However,
should the medication be tampered with, such as injecting the
buprenorphine/naloxone combination, naloxone then becomes the dominant
medication and will send the user into withdrawals (SAMHSA, 2016a).
By using buprenorphine as a replacement opioid, the patient is slowing
weaned off the medication over a period of several days, depending on the
individual’s severity of opioid abuse (Hakansson & Hallén, 2014). Buprenorphine
was successfully used to transition 89% of participants from detoxification into a
therapeutic community setting for continued therapy of their opioid addiction
(Collins, Horton, Reinke, Amass, & Nunes 2007). When compared with a control
group using clonidine for detoxification, buprenorphine was also associated with
longer lengths of stay (mean 5.74 vs. 3.51 days) (Kovas, McFarland, McCarty,
Boverman, & Thayer, 2007).Completion of the detoxification program was also
higher with buprenorphine vs. clonidine (67 vs. 46 completions, respectively)
(Kovas et al., 2007). Typically buprenorphine, or the buprenorphine/naloxone
combination, is started early in the detoxification process. The patient is then
slowly weaned off the medication over several days.
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Short-Term Residential Treatment and Completion of RTC
Short-term residential treatment programs has long been a mainstay of
treatment of substance use disorders. Many programs are based on the
Minnesota Model, which typically involves a 28-day stay for treatment . This may
include individual counseling and group therapy (Henninger & Sung, 2014).
Several indicators have been suggested as predictors of success in
substance use disorder (SUD) treatment, including demographics, history of drug
use, and various comorbidities. Dreifuss et al. (2013) found never having used
heroin or extended-release oxycodone, and no prior treatments for opioid misuse
were indicators of success (N = 360). Males have been found to have higher
lengths of success than females for treatment of opioid abuse in terms of
detoxification completion (N = 126) (Ekhtiari, Dezfouli, Zamanian, Ghodousi, &
Mokri, 2013). Males also were found to have better retention in treatment for
opioid use (N = 165) (Marsch et al., 2005). Older age predicted success when
defined as treatment retention at twelve months (N = 382) (Alford et al., 2011),
survey and UDS results (Dreifuss et al., 2013), or successful detoxification
(Ekhtiari et al., 2005).
Comorbidities of may include depression and antisocial personality.
Depression at high levels appears to improve chances of success in treatment
for cocaine and opioid misuse as measured by negative UDS (Marsch et al.,
2005) and retention (Dreifuss et al., 2013; Marsch et al., 2005). Antisocial
personality has been implicated with poor treatment success, demonstrated by
positive UDS for cocaine (Marsch et al., 2005).
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History of drug use may affect treatment success. Success in detoxification
was poor if heroin was the main drug of choice (Odds ratio [OR] = .25, p = .01)
as well as longer duration of opioid misuse (OR = .89, p = .024), based on having
negative UDS and last methadone daily dosage less than 15 mg as study
measures (N=126) (Ekhtiari et al., 2013). Using prescription opioids for euphoric
effects only, as well as obtaining opioids from an illegitimate source, were also
predictors of poor success in completing a 12-week stabilization program with
buprenorphine/naloxone and a corresponding four-week taper (Dreifuss et al.,
2013).
RTCs frequently are used once a patient has completed detoxification
treatment. Typically lasting around 30 days, patients in RTC stay for further SUD
treatment which includes counseling and introduction to social support groups,
such as Alcoholics Anonymous or Narcotics Anonymous (Henninger & Sung,
2014; SAMHSA, 2018). RTC also appeared to enhance the likelihood of
continued engagement in 12-step programs and improved coping skills in
emerging adults (N = 292) (Schuman-Olivier, Greene, Bergman, & Kelly, 2014).
Opioid users (n =1160) were found to have a length of stay in RTC that was
approximately 2 days shorter (30.9 vs. 32.8 days) than non-opioid users (n =
768) (Bride et al., 2016). Those experiencing a nonfatal opioid overdose were
more likely to favor an RTC than other treatment options, including outpatient
MAT (N = 485) (Stein et al., 2017).
Several studies have examined success at different types of clinical sites.
Success in a primary care buprenorphine treatment program for OUD was
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defined as program retention demonstrated by negative UDS testing for illicit
drugs while still testing positive for buprenorphine, and attending required
counseling appointments (Alford et al., 2011). Primary care benzodiazepine
detoxification success was measured as not receiving a benzodiazepine from the
general practitioner in the follow-up period of 15 months (N = 170) (Voshaar et
al., 2006). Success in an outpatient therapy group for alcohol dependence was
defined as attending all therapy sessions and abstaining from alcohol for 12
weeks (N = 298) (Young et al., 2011). Successful outpatient buprenorphine
detoxification for OUD in youth aged 15-21 was defined as opiate-negative UDS
at 12 weeks (N = 152) (Subramaniam et al., 2011). Successful outpatient OUD
detoxification with methadone was defined as negative UDS and retention in the
program, as well as last daily methadone dosage of 15mg or less (Ekhtiari et al.,
2013).
Few studies have examined short-term RTC completion, as well as examining
detoxification prior to RTC as a predictor of RTC completion. Both of these
factors indicate a gap in knowledge of treatment of OUD. It is imperative to have
an understanding of predictors of completion, particularly in short-term residential
treatment. Predictors of completion in RTC may be different from those in other
settings, necessitating alterations in treatment approaches. This study will
address this gap in knowledge by examining predictors of RTC completion so
interventions can be developed to improve health outcomes as well as increase
the potential for recovery in individuals with OUD. As there is a current opioid use
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crisis in the U.S., knowledge of effective treatment is essential for these
individuals.
Conceptual Framework
This study is conceptually guided by Barker's Tidal Model of Mental Health
Recovery (Buchanan-Barker & Barker, 2015). The Tidal Model acknowledges
that recovery is a process, with the healthcare provider helping OUD patients to
discover their own path to recovery. The model accepts that recovery is
possible, and that the provider needs to be creative in approaching the patient's
recovery (Young, 2010). The idea of recovery is at the heart of overcoming any
addiction (Alcoholics Anonymous, 2013; Narcotics Anonymous, 2018).
The Tidal Model emphasizes encouraging patients to learn what they can do
in the face of a problem - in this case, opioid addiction. The premise of the Model
is not to relieve patients of their addiction, but to allow them to find within
themselves the means to deal with addiction, and thus live a productive life
(Buchanan-Barker & Barker, 2015). This is essential to recovery. Predictors of
completion may mirror an individual’s lived experience. Understanding the lived
experience is also essential in promoting recovery (University of Birmingham,
2008)
Creativity in tailoring treatment to the individual is essential, and understanding
predictors of completion will help nurses, counselors, physicians tailor care to
such predictors present in an individual.
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Innovation
Understanding those variables that do or do not predict completion of RTC is
key. Understanding of variables that lead to RTC completion can assist with
treatment modification. This study is innovative in seeks to understand
predictors of RTC completion and decrease the gap of knowledge regarding the
linkage between medically supervised detoxification and completion of RTC for
OUD. This may result in a clinical paradigm shift, as more specific interventions
can be tailored to those with OUD.
Research Approach
Design and Setting
The design of this study will be of a retrospective cohort study in the form of a
record review of clients who received treatment for OUD from Cenikor
Foundation. Cenikor provides treatment for substance use disorder in Texas and
Louisiana. The four short-term RTC locations are in Texas: Austin, Houston,
Tyler, and Waco.
Population, Sample, Sampling Procedures
Only those with any type of opioid as a primary drug of choice and who were
clients of Cenikor's RTC from 2012 to July 2018 will be included. Exclusion
criteria will be individuals less than 18 years of age. The population size will be
fixed based on the data provided for each of the four RTC locations.
Cenikor will provide de-identified data from the four RTCs along with the
corresponding detoxification data for analysis. The study team will not know
names of individuals. The study protocol will be approved by the Committee for
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the Protection of Human Subjects at the University of Texas Health Science
Center at Houston (UTHSCH).
Measurements
Specific aim 1
To examine if demographics, social factors, drug history, and co-morbid
diagnoses predict completion of a short-term residential treatment center in those
with OUD.
The hypothesis is that demographics, social factors, drug history, and comorbid diagnosis predict completion of a short-term residential treatment center.
Completion will be measured by indicating if participants finished the 28-day
RTC program at Cenikor. The Appendix illustrates the intake form utilized by
Cenikor, providing demographic and other background information on the client.
Demographic data to be collected will include age, sex, race, level of education,
area of residence as determined by first two numbers of client's zip code, length
of stay in treatment, and reason for discharge.
Social factors will include legal problems, living situation, and employment.
Legal problems will be measured by participants answering “Yes” or “No” to a
series of legal questions. For living situation, participants will check which of the
following are true: adult living independently; homeless; jail; living with friends;
single adult living with family; transient living situation; other.
Data on drug history will include type of opioid(s) used and subclassified into
primary, secondary, tertiary drug of choice, where available. Methods of drug
administration, length of use, and age of first use will also be variables for drug
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history. Prior history of treatment will also be examined, with number of prior
treatments examined, where available.
Comorbid medical and psychiatric diagnoses will be measured by participants
using a checklist of diagnoses as to whether they have ever been diagnosed with
a specific disorder. Information regarding age of diagnosis and history will also
be noted.
Specific aim 2
To investigate if there is a relationship between undergoing detoxification or
not prior to entry into RTC that predicts completion of short-term residential
treatment.
The hypothesis is that those who undergo OUD detoxification prior to RTC
entry are less likely to complete short-term residential treatment than those who
do not undergo OUD detoxification.
Data regarding detoxification will be examined, to include length of
detoxification, number of prior detoxifications, and specific opioid(s) of abuse.
Characteristics of those not continuing into RTC will be examined. Detoxification
as a predictor of RTC completion will also be examined.
Data Analysis
Specific aim 1
To examine if demographics, social factors, drug history, and co-morbid
diagnoses predict completion of a short-term residential treatment center in those
with OUD.
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The hypothesis is that demographics, social factors, drug history, and comorbid diagnosis predict completion of a short-term residential treatment center.
Data provided from Cenikor's four RTC's will be transposed to SPSS for
statistical analysis. Using SPSS, descriptive statistics will be computed on all
variables. Data will be examined for outliers, as well as potential data errors.
Data errors that are verifiable will be corrected; errors that cannot be verified will
be coded as missing. To determine correlation of continuous and binomial
variables, correlation tables using Pearson’s correlation and Spearman's rank
order coefficient (rho) will be generated. Histograms will be generated for each
continuous variable to determine normality.
Power analysis was computed using G-Power 3.0.10. Based on a Chi
Square with effect size of .3, alpha of .05, beta of .95, with one degree of
freedom (based on completion of RTC with the nominal answers of yes or no), a
total sample size for each treatment location was determined to be 145.
Generalized linear models will be generated with logistic regression.
Categorical variables will be regressed against length of stay to determine if
length of stay is predictable. Length of use will also be regressed against LOS
as well and RTC completion. Survival analysis of time to drop-off will also be
examined. As data has already been collected, it is expected that the project will
be completed in three to four months, with the majority of that timeframe spent on
data translation to SPSS.
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Specific aim 2
To investigate if there is a relationship between undergoing detoxification or
not prior to entry into RTC that predicts completion of short-term residential
treatment.
The hypothesis is that those who undergo OUD detoxification prior to RTC
entry are less likely to complete short-term residential treatment than those who
do not undergo OUD detoxification.
Data provided from Cenikor's four RTCs’ corresponding detoxification
facilities will be transposed to SPSS for statistical analysis. Using SPSS,
descriptive statistics will be computed on all variables. Data will be examined for
outliers, as well as potential data errors. Data errors that are verifiable will be
corrected; errors that cannot be verified will be coded as missing. To determine
correlation of continuous and binomial variables, correlation tables using
Pearson’s correlation and Spearman's rank order coefficient (rho) will be
generated. Histograms will be generated for each continuous variable to
determine normality.
Logistic regression will be utilized to examine whether detoxification is
predictive of completion of RTC, as well as number of prior detoxifications.
Differences between those who completed detoxification prior to RTC and those
entering directly into RTC will also be examined.
Study Limitations
The main risk of this project is managing the confidentiality of the data
provided by Cenikor. The data will be de-identified by Cenikor before it will be
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given to the PI. However, the data set is expected to be large, and the potential
for identifying data being passed on does exist. In such circumstances, Cenikor
will be made aware of the identifiable data. Such instances will be excluded from
the study.
Human Subjects
Risks to the individual clients will be quite minimal, as all data will be deidentified by Cenikor prior to release to the study team. Individual clients will only
be identified by a code. All data will be stored on a password-protected flash
drive to also ensure data privacy. At the end of the study, all data will be
destroyed and any papers containing data will be shredded.
Benefits will include a better understanding of predictors of RTC completion
regarding whether detoxification was necessary or not. Such knowledge would
be helpful in tailoring an individual's treatment program to increase the likelihood
of RTC completion.
Timeline
As data have already been collected, the length of time for this project is
expected to be about two to three months. The majority of time spent on this
project will involve examining the de-identified data provided by Cenikor and
"cleaning" the data so that it may be used in an SPSS format, which perhaps
may take up to three to four months. Once examined in SPSS, the results will be
interpreted, and a written analysis of the findings will be produced.
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Budget
Since data have already been collected, and the primary investigator (PI)
leases SPSS for concurrent schoolwork with UTHSCH Cizik School of Nursing,
no other budgetary needs are anticipated. A security-coded flash drive will be
used to store all data and material for this project and will be maintained by the
PI.
Facilities & Other Resources
The University of Texas Health Science Center at Houston
Established in 1972 by The University of Texas System Board of Regents,
The University of Texas Health Science Center at Houston (UTHealth) is
Houston’s Health University and Texas’ resource for health care education,
innovation, scientific discovery and excellence in patient care. The most
comprehensive academic health center in The UT System and the U.S. Gulf
Coast region, UTHealth is home to schools of biomedical informatics, biomedical
sciences, dentistry, nursing and public health and the John P. and Kathrine G.
McGovern Medical School. UTHealth includes The University of Texas Harris
County Psychiatric Center and a growing network of clinics throughout the
region. The university’s primary teaching hospitals include Memorial HermannTexas Medical Center, Children’s Memorial Hermann Hospital and Harris Health
Lyndon B. Johnson Hospital.
UTHealth Cizik School of Nursing
The University of Texas Health Science Center at Houston (UTHealth) Jane
and Robert Cizik School of Nursing, established in 1890 as part of the John
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Sealy Hospital Training School for Nurses in Galveston, is one of the oldest
schools of nursing in the southwestern United States. The baccalaureate nursing
program of the UT System expanded to Houston in 1972, the same year that the
UT Health Science Center came into being. The Cizik School of Nursing was
organized in 1972 and began offering the master of nursing degree in the same
year. In 1976, the system structure dissolved and the School of Nursing was
reorganized under the control of the health science center. The School initiated
the Doctor of Science in Nursing degree program in 1995 (changed to the PhD in
Nursing in 2007) and the Doctor of Nursing Practice degree program in 2006.
Cizik School of Nursing is ranked in the top five percent of graduate nursing
programs in the country, according to the latest survey results by U.S. News and
World Report. The School of Nursing is one of six academic units of UTHealth,
which is a component health institution of The University of Texas System. The
other UTHealth units, in chronological order of operation, are: School of Dentistry
(1905), Graduate School of Biomedical Sciences (1963), School of Public Health
(1967), Medical School (1970), and School of Biomedical Informatics (2000). The
campus is located in the world-famous Texas Medical Center, where students
enjoy the resources of a distinguished health science center combined with the
expertise and inter-disciplinary collaborative opportunities of the world's largest
medical center. Faculty members hold joint appointments at the Medical School,
School of Public Health, School of Biomedical Informatics, and many Houstonarea hospitals and health care agencies, including the UT MD Anderson Cancer
Center.
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Cenikor Foundation
The Cenikor Foundation is a not- for- profit, CARF accredited, organization
that provides substance abuse services to adolescents & adults. Cenikor
provides four treatment options for clients struggling with their addiction: Detox
programs, Residential Treatment, Intensive Outpatient programs and long term
Therapeutic Communities. Cenikor offers evidenced-based treatment and
accredited programming, within a credentialed infrastructure, with the support of
licensed clinical staff to support men, women and adolescents on their individual
path to recovery. With a continuum of care, clients have the opportunity to seek
the program that best suits their immediate needs and to move into other
programs as their need changes. Cenikor is dedicated to finding the right level of
care for individual client's path to sobriety.
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Predictors of Short-term Residential Treatment Completion
Preceded by Detoxification for Opioid Use Disorder
Introduction
Mortality rates from opioid overdose are on the rise. Mortality from opioid
overdose increased from 29,813 in 2005 to 52,404 in 2015 (National Institute on
Drug Abuse [NIDA], 2017a). Heroin has seen a steep increase in overdose
deaths from just over 2,000 in 2010 to 15,446 deaths in 2016, equating to a sixfold increase over six years. Synthetic opioids such as fentanyl (other than
methadone) have seen an even greater spike in overdose deaths. In 2013 there
were approximately 3,000 deaths and over 20,000 in 2016 (NIDA, 2017b).
Treatment is necessary to help prevent relapse and promote remission for
people with opioid use disorder (OUD). This in turn should lead to a decrease in
the number of opioid overdoses.
Medically-Supervised Opioid Detoxification
Detoxification for OUD is often the first step for patients seeking treatment.
Medically-supervised detoxification typically includes an inpatient hospitalization
and monitoring while the symptoms of opioid withdrawal are managed
pharmacologically (Kleber, 2007). The patient may also undergo individual and
group therapy during this phase of treatment (Kleber, 2007).
Opioid detoxification often involves giving patients opioid replacement
medications, such as buprenorphine. Patients in this treatment are slowly
weaned off the medication over a period of several days, depending on the
severity of withdrawal symptoms experienced (Hakansson & Hallén, 2014).
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Although buprenorphine was the medication used for detoxification in the current
study, the medication was not continued into short-term residential treatment as
a form of medication-assisted treatment (MAT).
Predictors of Outcome in Substance Use Disorder Treatment
Several variables have been suggested as predictors of OUD treatment
outcome, including demographics and history of drug use. Dreifuss et al. (2013)
found that never having used heroin or extended-release oxycodone, and no
history of prior treatment for opioid misuse predicted success, defined as
negative urine drug screen, in a sample of 360 participants with OUD. Longer
lengths of opioid misuse prior to treatment were more likely to continue to misuse
when compared to those with lower levels of misuse (Brewer, Catalano,
Haggerty, Gainey, & Fleming, 1998). Patients with repeated detoxifications were
less likely to pursue further treatment (Carrier et al., 2011). Patients attending
rehabilitation only had a longer average length of stay in treatment compared to
those requiring detoxification before rehabilitation (Blanchard et al., 2019),
In terms of gender, males have been found to complete OUD detoxification
more frequently than females. (N = 126) (Ekhtiari, Dezfouli, Zamanian, Ghodousi,
& Mokri, 2013). Males were also found to have better retention in OUD treatment
than females (N = 165) (Marsch et al., 2005). Older age predicted success when
defined as treatment retention at twelve months (N = 382) (Alford et al., 2011),
survey and urine drug screen results (Dreifuss et al., 2013), or successful
detoxification (Ekhtiari et al., 2005).
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History of drug use may also affect treatment outcomes. Outcome in
detoxification was poor if heroin was the main drug of choice (Odds ratio [OR] =
.25, p = .01) or if the opioid use was of a longer duration. (OR = .89, p = .024),
This was based on having a negative urine drug screen and last methadone daily
dosage less than 15 mg as study measures (N = 126) (Ekhtiari et al., 2013).
Having used prescription opioids for euphoric effects only or obtaining opioids
from an illegitimate source, were also predictors of poor outcomes in completing
a 12-week stabilization program with buprenorphine/naloxone and a
corresponding four-week taper (Dreifuss et al., 2013).
Several studies have examined the definitions of treatment completion at
different types of clinical sites. Successful completion in a primary care
buprenorphine treatment program for OUD was defined by negative urine drug
screen testing for illicit drugs (other than buprenorphine) and attending required
counseling appointments (Alford et al., 2011). Primary care benzodiazepine
detoxification completion was defined as not receiving a benzodiazepine from the
general practitioner in the follow-up period of 15 months (N = 170) (Voshaar et
al., 2006). Attendance at all therapy sessions and abstaining from alcohol for 12
weeks (N = 298) (Young et al., 2011) defined success in an outpatient therapy
group for alcohol dependence. Completion of outpatient buprenorphine
detoxification for OUD in youth aged 15-21 years old was defined as opiatenegative urine drug screen at 12 weeks (N = 152) (Subramaniam et al., 2011).
The definition of successful outpatient OUD detoxification with methadone was a
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negative urine drug screen and retention in the program, as well as last daily
methadone dosage of 15mg or less (Ekhtiari et al., 2013).
Short-Term Residential Treatment
Short-term residential treatment programs have long been a mainstay of
treatment of substance use disorders and frequently are used once a patient has
completed detoxification treatment. Patients in short-term residential treatment
stay for approximately 30 days, receiving further substance use disorder
treatment which includes counseling and introduction to mutual support groups,
such as Alcoholics Anonymous or Narcotics Anonymous (Henninger & Sung,
2014; SAMHSA, 2018). Short-term residential treatment was found to enhance
the likelihood of continued engagement in 12-step programs and improve coping
skills in emerging adults aged 18 to 25 years (N = 292) (Schuman-Olivier,
Greene, Bergman, & Kelly, 2014). Patients with OUD (n =1160) were found to
have a length of stay in short-term residential treatment that was approximately 2
days shorter (30.9 vs. 32.8 days) than those who did not use opioids (n = 768)
(Bride et al., 2016). People experiencing an opioid overdose were more likely to
favor a short-term residential treatment than other treatment options, including
outpatient medication-assisted treatment (N = 485) (Stein et al., 2017).
Employment is a form of recovery capital, representing a strength in
maintaining recovery for the long-term. Employment recovery capital has been
shown to predict successful completion (defined as reported abstinence at six
months post-treatment) across various methods of substance use disorder
treatment, including as residential treatment and intensive outpatient (Sahker, Ali,
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& Arndt, 2019). Employment has also been shown to be related to a cessation or
a decreased use of heroin (Hser, Evans, Grella, Ling, and Anglin, 2015).
Few studies have examined short-term residential treatment completion, as
well as examining detoxification prior to short-term residential treatment as a
predictor of short-term residential completion for OUD. It is imperative to have an
understanding of predictors of completion, particularly in short-term residential
treatment, as these predictors of may be different from those in other treatment
settings, necessitating alterations in treatment approaches.
The current study addresses this gap in knowledge by examining predictors
of short-term residential treatment completion as a first step to developing and
testing interventions that can improve health outcomes as well as increase the
potential for remission and recovery in individuals with OUD. As there is a current
opioid use crisis in the U.S., knowledge of effective treatment is essential for
these individuals.
Based on previous studies, expected predictors of short-term residential
completion include males (Ekhtiari et al., 2013; Marsch et al., 2005) and older
age (Alford et al., 2001), and employment (Sahker, Ali, & Arndt, 2019). Heroin
use (Ekhtiari et al., 2013) and higher frequency of use (Brewer et al., 1998)
would not be predictive of completion. In regards to completion of short-term
residential treatment preceded by detoxification, it was expected that
detoxification would not be predictive of short-term residential treatment
completion (Blanchard et al., 2019; Carrier et al., 2011).
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The specific aims and hypotheses of this study were to: (1) Examine if
demographics, social factors, and drug history predict completion of a short-term
residential treatment center. It was hypothesized that male gender, older age,
and being employed would be predictive of short-term residential treatment
completion, while opioids stronger than or equal to morphine, and higher
frequency of opioid misuse would not be predictive of completion; and (2)
investigate whether there is a relationship between undergoing detoxification or
not prior to entry into short-term residential treatment. It was hypothesized that
individuals who undergo OUD detoxification prior to short-term residential
treatment entry are less likely to complete short-term residential treatment than
those who do not undergo OUD detoxification.
Methods
Design and Setting
The design of this study was a retrospective cohort study. Data was obtained
from a review of client’s records who received OUD treatment in a substance
abuse disorder treatment organization located in Texas. This organization
operates four short-term residential treatment programs for adults at four
locations: Central Texas (sites 1 and 3), one in Northeast Texas (site 2), and
Southeast Texas (site 4).
Population and Sampling Procedures
Adults with a diagnosis of OUD and who participated in one of the four shortterm residential treatment programs from July 2014 to December 2018 were
included. Individuals less than 18 years of age were excluded. The population
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size was determined by the data provided by each of the four treatment
locations. De-identified data extracted from the client records and corresponding
detoxification data was provided by the organization’s four short-term residential
treatment sites. The study protocol was approved by the Committee for the
Protection of Human Subjects at the University of Texas Health Science Center
at Houston.
Measurements
Appendix A illustrates the intake form utilized by the treatment organization,
providing demographic and other information on the client. Demographic data
collected included age, sex, religion, marital status, race, veteran status, type of
insurance/payment, and area of residence as determined by first three numbers
of the patient's zip code.
Social factors included employment and legal problems classification. Legal
problems were classified based on a multilevel categorical independent variable,
including walk-ins, parole, probation, legally suggested referral, and court
mandated. Levels of employment included unemployed, employed full-time, and
employed part-time.
Data on drug use history and primary opioid of choice were examined. The
opioid of choice variable was categorized based on relative strength using
morphine milligram equivalents (MME) as recommended by the State of Ohio
Board of Pharmacy (2017). MME levels included (a) MME stronger than
morphine (buprenorphine, fentanyl, hydromorphone, methadone, and
oxycodone); (b) MME equal to morphine (morphine and hydrocodone); and (c)

PREDICTORS OF SHORT-TERM RESIDENTIAL

41

MME weaker than morphine (codeine, tramadol, and others). Heroin was kept
as a separate level due to its illegal status. Routes of drug administration,
frequency of use in the last 30 days, and age of first use were also variables of
interest for drug history. Prior history of treatment was also examined by the
number of prior treatments, whether those treatments were completed or not.
To accommodate the large range of abbreviated first 3-digit zip codes
represented in this study, the codes were condensed to geographic regions:
Austin Area, Dallas/Ft. Worth Area, Houston Area, North and West Texas,
Northeast Texas, San Antonio/South Texas, Waco Area, and Outside Texas.
Completion of short-term residential treatment was defined as staying in
the program for 28 days, or as deemed by the organization’s clinical staff as
having reached completion goals. Data examined regarding residential
treatment completion included length of stay in detoxification, number of prior
treatment episodes, and specific opioid of choice. Detoxification as a predictor of
short-term residential treatment completion was the primary independent variable
of interest, and was examined first as a dichotomous (yes or no) variable, and
then as a continuous variable by length of stay in detoxification. This was to
address possible collinearity between the two primary independent variables of
interest.
Data Analysis
Data provided from the organization’s four treatment sites were transposed to
the Statistical Package for the Social Sciences (SPSS, version 24), for statistical
analysis. Descriptive statistics were computed on all variables. Verifiable data
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errors were corrected; errors that could not be verified were coded as missing.
Chi-square and Mann-Whitney U tests were calculated to determine statistically
significant association between the dependent variables and independent
variables. Significant variables were to be entered into the binomial logistic
regression analyses. To determine association of continuous and binomial
variables, Mann-Whitney U tests were conducted on continuous independent
variables and both the dichotomous dependent variable of short-term residential
treatment completion and the primary independent variable of detoxification
before short-term residential treatment. Pearson’s Chi-square was calculated for
all categorical independent variables and the dependent variable.
Power analysis was computed using G-Power 3.0.10 (Faul, Erdfelder, Lang,
& Buchner, 2007). Based on a Chi-square with effect size of .3, alpha of .05,
beta of .95, with one degree of freedom (based on completion of short-term
residential treatment with the nominal answers of yes or no), a total sample size
for each treatment location was determined to be 145.
Data from the combined treatment sites were used to assess odds ratios
for each separate independent variable using binary logistic regression for the
dependent variable. Odds ratios were adjusted by adding the other statistically
significant independent variable identified by Chi-square and Mann-Whitney U
results into the binary logistic regressions. Patient age and variables that were
not significant, but related to history of drug use, were also added to the
regression to examine drug use history.
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Separate binary logistic regressions were run for the dependent variable of
completion of short-term residential treatment and the primary independent
variables. One regression examined the dichotomous primary independent
variable of detoxification prior to short-term residential treatment (yes or no), as
well as variables with statistically significant Mann-Whitney or Chi-Square results
for both the dependent variable and primary independent variables The second
regression replaced the dichotomous detoxification variable with the continuous
primary independent variable of length of stay in detoxification, while keeping the
previously mentioned significant independent variables. This was to examine if
length of stay in detoxification affected short-term residential treatment
completion
The dichotomous primary independent variable of detoxification prior to shortterm residential treatment was examined as a predictor of completion of shortterm residential treatment. Detoxification length of stay was separately
regressed against the dependent variable (without the dichotomous detoxification
variable) to see if the continuous variable yielded different results in regards to
short-term residential completion.
Results
The total study population was 1001. The sample sizes for sites 3 and 4 (n =
181 and n = 169, respectively) were smaller than sites 1 and 2 (n = 423 and n =
228, respectively). The average age was 36.06 years, while the average age of
first opioid use was 24.35 years. Males accounted for 57.5% of the sample.
Seven hundred forty-four clients underwent detoxification. The average length
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of stay in short-term residential treatment was 16.85 days, while the average
length of stay in detoxification was 5.37 days. The average number of prior
treatment episodes was 0.16. Heroin was the most frequent opioid of choice (n=
514) and intravenous injection the most common form of drug use (45.6%). The
Houston, Texas area was the most common area of residence (22.00%).
Frequencies of demographics and other variables may be found in Table 1.
Several cases (n = 239) had larger amounts of missing data, particularly for
Legal Classification and Marital Status, as well as specific drug use data,
requiring those cases to be excluded from the study prior to statistical testing,
resulting in the total population size of 1001.
Specific Aim One
For specific aim one, it was hypothesized that demographics, social factors,
and drug use history would predict completion of short-term residential treatment.
Mann-Whitney U tests were conducted for the continuous independent variables
and the dependent variable of short-term residential treatment completion. The
same tests were run for the primary independent variable of detoxification prior to
short-term residential treatment (Table 2). Length of stay in detoxification was
statistically significant in relation to completion of short-term residential treatment
(p < .001), as was detoxification prior to short-term residential treatment (p <
.001; Table 2). Frequency of use during the last 30 days was also significantly
associated in relation to both short-term residential completion and detoxification
prior to short-term treatment (p = .005 and p < .001, respectively).
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Chi-square tests were performed to examine associations between the
categorical independent variables and the dependent variable of short-term
residential completion and the dichotomous primary independent variable of
detoxification prior to short-term residential treatment (Table 3). Treatment
Location (p = .024), Gender (p = .001), Route of Administration (p = .035), Opioid
of Choice (p = .041), and Employment Status (p = .014) emerged as significant
predictors. Treatment Location (p < .001), Opioid of Choice (p = .013), Legal
Classification (p = .011), Payer Type (p < .001), and Geographic Location (p =
.025) were significantly associated with detox prior to residential treatment.
Although Legal Classification was significant, it was not entered into the
regression due to the large amount of missing data (n = 365, or 36.5%).
Each statistically significant variable was examined for odds ratios (OR) and
adjusted odds ratios (aOR) for short-term residential treatment completion (Table
4). Those treated at Site 2 were 1.497 (aOR) times more likely to complete
short-term residential treatment (p = .041) than those at Site 1. Clients at site 3
were 2.967 times more likely to not complete short-term residential treatment
when compared to those from Site 1 (aOR = .337, p = .042).
Males were 1.689 times (aOR) times more likely to complete short-term
residential treatment than females (p = .002). Those who inhaled opioids was
2.342 times (aOR) more likely to complete short-term residential treatment
compared to those using intravenous injection (p = .022). Those that were
employed full-time were more than twice as likely to complete short-term
residential treatment compared to those who were unemployed (aOR = 2.231, p
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= .049). Frequency of opioid use over the 30 days prior to entering treatment
was not statistically significant for completion of short-term residential treatment
(p = .051).
Specific Aim Two
For specific aim two, it was hypothesized that individuals who undergo OUD
detoxification prior to short-term residential treatment entry are less likely to
complete short-term residential treatment than those who do not undergo OUD
detoxification. This was examined with prior detoxification as a dichotomous
variable, and then as a continuous variable in the form of length of stay in
detoxification as the primary independent variable.
Detoxification prior to short-term residential treatment as main predictor
Referring to Table 5, detoxification prior to short-term residential treatment
yielded an OR 1.402 (p = .022), indicating that those who did not undergo
detoxification prior to short-term residential treatment were more likely to
complete; however, the aOR of 1.302 for the same primary independent variable
was not significant (p = .123). Males were 1.556 (aOR) times more likely to
complete short-term residential treatment (p = .001). Those using Medicaid as a
primary method to pay for treatment had an aOR of .516 (p = .019), translating to
being 1.938 times more likely to not complete short-term residential treatment
when compared to those using another state-sponsored program to pay for
treatment.
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Detoxification length of stay as main predictor
For every day in detoxification, a client was 1.042 times more likely to not
complete short-term residential treatment (aOR = .960, p = .032). Males were
1.554 times more likely to complete short-term residential treatment (p = .001).
Those using Medicaid had an aOR of .496 for completing short-term residential
treatment (p = .013).
Discussion
This study found that males, full-time employment, and nasal use of opioids
were predictors of short-term residential treatment completion. Those treated at
Site 2 were more likely to complete short-term residential treatment, while those
at Site 3 were less likely to complete residential treatment for OUD. Frequency
of use during prior to entering treatment was not statistically significant to shortterm residential treatment completion. Detoxification prior to short-term treatment
did not predict completion of short-term residential treatment for OUD, supporting
the second hypothesis.
Results from this study found that the more days individuals spent in
detoxification for OUD, the less likely they were to complete short-term
residential treatment. This may arise from a belief that one is “cured” once the
detoxification process is complete. Kleber (2007) noted that therapists reported
many patients taking buprenorphine or methadone for maintenance of OUD may
refuse counseling due to their feeling of wellness. Fifty-two per cent of OUD
clients using extended-release naltrexone patients “felt cured,” and opted to
discontinue the treatment (Williams et al., 2017). These sentiments may be
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similar for not completing short-term residential treatment. Other possibilities
include lack of funding to continue short-term residential treatment, or insurance
cutting off funding at a given number of days in short-term residential treatment.
Stein et al. (2017) found that only 11% of those completing detoxification
preferred short-term residential treatment, while a majority preferred outpatient
medication-assisted treatment. The current findings suggest the use of
medication-assisted treatment into short-term residential treatment, as this may
allow the patient to help fight cravings for opioids (U.S. Department of Health and
Human Services, Office of the Surgeon General [HHS], 2018), and thus remain
in treatment for a longer length of time.
Treatment Site 2 demonstrated a higher odds ratio for completing short-term
residential treatment compared to Site 1. One possibility is that heroin was not
the most frequently reported opioid of choice; rather, opioids with an MME equal
to morphine were more frequently reported, which included hydrocodone.
Those using nasal inhalation of opioids demonstrated better chances of
completing short-term residential treatment when compared to those using
intravenous injections of drugs. This was an interesting finding, but may be due
to the lower number of those reporting nasal usage (n = 76 compared to n = 744
for intravenous injection). Frequency of opioid use in the last 30 days was not
statistically significant for the model of demographics and drug use (aOR = .984,
p = .051). The same was true in the other regressions examined with the primary
independent variable of detoxification before short-term residential treatment (p =
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.180), as well as for the primary independent variable of length of stay in
detoxification (p = .260).
Older age was not statistically significant for completion of short-term
residential treatment; this is in contrast to others studies that found improved
retention with older age (Alford et al., 2011; Dreifuss et al., 2013; Ekhtiari et al.,
2005). Males were more likely to complete short-term residential treatment for
OUD. Barriers for women and OUD treatment may include economic difficulties,
family responsibilities, and feelings of shame (Green, 2006).
Being employed full-time demonstrated a higher aOR for completing shortterm residential treatment when compared to those who were unemployed. This
is consistent with Hser et al. (2015), who suggest employment helps provide
structure to those in recovery. Type of vocation was not examined in this study,
but may be of interest for future research. Employment may also allow one to
afford health insurance, although commercial insurance or private pay did not
figure significantly with short-term residential treatment completion with either
primary independent variable (Table 5). Employment recovery capital has been
shown to predict treatment completion, particularly when there is an improvement
in employment recovery capital (Sahker et al., 2019). Those using Medicaid
were 1.94 times less likely to complete short-term residential treatment
(dichotomous primary independent variable aOR = .516 for short-term residential
treatment completion, p = .019) than those in a state-sponsored program. This
was also true for the continuous primary independent variable of length of stay in
detoxification (aOR = .496, p = .013).
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Limitations
Limitations to this study involve the available data set. The sample sizes for
sites 3 and 4 were smaller than sites 1 and 2, possibly owing to the fact that sites
3 and 4 are the most recent additions to the organization’s short-term residential
treatment locations in Texas, and therefore fewer clients. As this study was
retrospective in nature, data was limited to what had been entered into the data
base. Since the data had been de-identified, it was not possible to speak with
specific clients to verify missing data, particularly for the variables of Legal
Classification and Marital Status.
Missing data for legal status and marital status prevented those variables
from being entered into the regression equation by SPSS; this was part of the
reason for only examine the combined sites population and not each site
individually. Logistic regression requires larger sample sizes to provide reliable
results (Leech, Barrett, & Morgan, 2015); site 3 and 4 had smaller populations (n
= 181 and n = 169, respectively). The sample sizes themselves were adequate
for regressions, but when cases with missing data were removed by SPSS, the
resulting sample sizes were inadequate for reliable regression results.
Implications for Practice and Research
The findings from this study raise implications for practice and future
research. Knowing that detoxification does not predict that one will complete
short-term residential treatment, addiction specialists should find ways of
reinforcing that detoxification is not a cure for OUD, but merely a beginning on
the road to recovery. The feeling of being cured once withdrawal symptoms
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have subsided presents a difficult barrier to overcome for continued OUD
recovery.
Future research should assess the differences among different treatment
locations in clients’ completion of short-term residential treatment . Site 2
exhibited higher odds ratios of residential completion, when compared to Site 1;
Site 3 subjects demonstrated lower odds rations of residential completion.
Assessing specific predictors for each location may help tailor treatment plans for
clients at each treatment location.
Further research examining factors related to gender and completion of shortterm residential treatment would also be of interest, including links to
socioeconomic factors. This may also be extended to full-time employment
being predictive of completion of short-term residential treatment, which may
influence what time of insurance or payment program is utilized. Having
Medicaid was also not predictive of short-term residential treatment completion in
this study. Further investigation into the relationship between gender,
employment status, and Medicaid should be examined, which may help in
developing interventions for completion of short-term residential treatment.
The treatment organization in the current study did not utilize medicationassisted treatment during short-term residential treatment. The United States
Surgeon General recent recognized medication-assisted treatment, along with
other rehabilitation services, as the gold-standard for treating OUD (HHS, 2018).
Use of medication-assisted treatment, however, may be blunted by certain
philosophical beliefs regarding treatment and recovery. Barriers to medication-
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assisted treatment include insufficient training, lack of institutional support, lack of
support by clinician peers, provider bias, and regulatory requirements (Haffajee,
Bohnert, & Lagisetty, 2018). It would be of interest to repeat the current study,
but with the addition of medication-assisted treatment, such as buprenorphine.
Conclusions
This study found that detoxification prior to short-term residential treatment
does not enhance one’s chance of completing short-term residential treatment.
This may be due to one’s belief of being cured once one undergoes
detoxification. Clients with Medicaid were not as likely to complete short-term
residential treatment, which is an aspect that bears further investigation. Nasal
inhalation of opioids predicted successful completion of short-term residential
treatment. Further investigation into route of administration may be of use, as
well as the influence of gender and full-time employment on short-term
residential treatment completion. Understanding that detoxification prior to shortterm residential treatment does not predict completion of residential treatment
may be useful in helping addiction specialists in promoting continuation of care
for opioid use disorder recovery.

PREDICTORS OF SHORT-TERM RESIDENTIAL

53

References
Alford, D. P., LaBelle, C. T., Kretsch, N., Bergeron, A., Winter, M., Botticelli, M., &
Samet, J. H. (2011). Collaborative care for opioid-addicted patients in primary
care using buprenorphine. Archives of Internal Medicine, 171(5), 425-431.
https://doi.org/10.1001/archinternmed.2010.541
Blanchard, J., Weiss, A. J., Barrett, M. L., Stocks, C., Owens, R., & Heslin, K. C.
(2019). Readmissions following inpatient treatment for opioid-related
conditions. Substance Use &b Misuse, 54(3), 473-481.
https://doi.org/10.1080/10826084.2018.1517174
Borkman, T., Kaskutas, L. A., & Owen, P. (2007). Contrasting and converging
philosophies of three models of alcohol/other drugs treatment: Minnesota
Model, Social Model, and addiction therapeutic communities. Alcoholism
Treatment Quarterly, 25(3), 21-38. https://doi.org/10.1300/J020v25n03_03
Brewer, D. D., Catalano, R. F., Haggerty, K., Gainey, R. R., Fleming, C. B.
(1998). A meta-analysis of predictors of continued drug use during and after
treatment for opiate addiction. Addiction, 93(1), 73-92. doi: 10.1046/j.13600443.1998.931738.x
Bride, B. E., MacMaster, S. A., Morse, S. A., Watson, C. M., Choi, S., & Seiters,
J. (2016). A Comparison of Opioid and Nonopioid Substance Users in
Residential Treatment for Co-Occurring Substance Use and Mental
Disorders. Social Work in Public Health, 31(7), 678–687.
https://doi.org/10.1080/19371918.2016.1188738

PREDICTORS OF SHORT-TERM RESIDENTIAL

54

Brorson, H. H., Arnevik, E. A., Rand-Hendriksen, K., & Duckert, F. (2013). Dropout from addiction treatment: A systematic review of risk factors. Clinical
Psychology Review, 33, 1010-1024. https://doi.org/10.1016/j.cpr.2013.07.007
Carrier, E., McNeely, J., Lobach, I., Tay, S., Gourevitch, M. N., & Raven, C.
(2011). Factors associated with frequent utilization of crisis substance use
detoxification services. Journal of Addictive Diseases, 30(2), 116-122.
https://doi.org/10.1080/10550887.2011.554776
Dreifuss, J. A., Griffin, M. L., Frost, K., Fitzmaurice, G. M., Potter, J. S., Fiellin, D.
A., . . . Weiss, R. D. (2013). Patient characteristics associated with
buprenorphine/naloxone treatment outcome for prescription opioid
dependence: Results from a multisite study. Drug and Alcohol Dependence,
131, 112-118. http://dx.doi.org/10.1016/j.drugalcdep.2012.12.010
Earley, P. H., Zummo, J., Memisoglu, A., Silverman, B. L., & Gastfriend, D. R.
(2017). Open-label study of injectable extended-release naltrexone (XR-NTX)
in healthcare professionals with opioid dependence. Journal of Addiction
Medicine, 11(3), 224-230. doi:10.1097/ADM.0000000000000302
Ekhtiari, H., Dezfouli, A., Zamanian, B., Ghodousi, A., & Mokri, A. (2013).
Treatment outcome predictors in flexible dose-duration methadone
detoxification program. Archives of Iranian Medicine, 16(10), 599-601.
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007). G*Power 3: A flexible
statistical power analysis for the social, behavioral, and biomedical sciences.
Behavior Research Methods, 39, 175-191. doi: 10.3758/BF03193146

PREDICTORS OF SHORT-TERM RESIDENTIAL

55

Green, C. A. (2006). Gender and use of substance abuse treatment services.
Alcohol Research & Health, 29(1), 55-62.
Haffajee, R. L., Bohnert, A. S. B., & Lagisetty, P. A. (2018). Policy pathways to
address provider workforce barriers to buprenorphine treatment. American
Journal of Preventive Medicine, 54(6), S230-S242. doi:
10.1016/j.amepre.2017.12.022
Hakansson, A., & Hallén, E. (2014). Predictors of dropout from inpatient opioid
detoxification with buprenorphine: A chart review. Journal of Addiction, 2014.
http://dx.doi.org/10.1155/2014/96526
Henninger A., & Sung, H. E. (2014). History of Substance Abuse Treatment. In:
G. Bruinsma & D. Weisburd (Eds.), Encyclopedia of criminology and criminal
justice. New York, NY: Springer.
Hser, Y.-I., Evans, E., Grella, C., Ling, W., & Anglin, D. (2015). Long-term course
of opioid addiction. Harvard Review of Psychiatry, 23(2), 76–89.
https://doi.org/10.1097/HRP.0000000000000052
Kleber, H. D. (2007). Pharmacologic treatments for opioid dependence:
Detoxification and maintenance options. Dialogues in Clinical Neuroscience,
9(4), 455–470.
Leech, N. L., Barrett, K. C., & Morgan, G. A. (2015). IBM SPSS for intermediate
statistics: Use and interpretation (5th ed.). New York, NY: Routledge.
Marsch, L. A., Stephens, M. A. C., Mudric, T., Strain, E. C., Bigelow, G. E., &
Johnson, R. E. (2005). Predictors of outcome in LAAM, buprenorphine, and

PREDICTORS OF SHORT-TERM RESIDENTIAL

56

methadone treatment for opioid dependence. Experimental and Clinical
Psychopharmacology, 13(4), 293-302. doi:10.1037/1064-1297.13.4.293
National Institute on Drug Abuse. (2017a). National overdose deaths from select
prescription and illicit drugs. Retrieved from:
https://www.drugabuse.gov/sites/default/files/overdose_data_1999-2015.xls
National Institute on Drug Abuse. (2017b). Overdose death rates. Retrieved from:
https://www.drugabuse.gov/related-topics/trends-statistics/overdose-deathrates
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016). Increases in
drug and opioid overdose deaths – United States, 2000-2014. Morbidity and
Mortality Weekly (MMWR), 64(50), 1378-1382. Retrieved from:
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6450a3.htm
Sahker, E., Ali, S. R., & Arndt, S. (2019). Employment recovery capital in the
treatment of substance use disorders: Six-month follow-up observations. Drug
and Alcohol Abuse, 205, 1-8. doi: 10.1016/j.drugalcdep.2019.107624
Schuman-Olivier, Z., Claire Greene, M., Bergman, B. G., & Kelly, J. F. (2014). Is
residential treatment effective for opioid use disorders? A longitudinal
comparison of treatment outcomes among opioid dependent, opioid misusing,
and non-opioid using emerging adults with substance use disorder. Drug and
Alcohol Dependence, 144, 178–185.
https://doi.org/10.1016/j.drugalcdep.2014.09.009
State of Ohio Board of Pharmacy. (2017, August 16). Oral morphine milligram
equivalent conversion table. Retrieved from:

PREDICTORS OF SHORT-TERM RESIDENTIAL

57

https://www.ohiopmp.gov/Documents/MorphineEquivalentDailyDoseConversi
onTable.pdf
Stein, M. D., Flori, J. N., Risi, M. M., Conti, M. T., Anderson, B. J., & Bailey, G. L.
(2017). Overdose history is associated with post detoxification treatment
preference for persons with opioid use disorder. Substance Abuse, 38(4),
389–393. https://doi.org/10.1080/08897077.2017.1353570
Subramaniam, G. A., Warden, D., Minhajuddin, A., Fishman, M. J., Stitzer, M. L.,
Adinoff, B., . . . Woody, G. E. (2011). Predictors of abstinence: National
Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in
opioid-dependent youth. Journal of the American Academy of Child &
Adolescent Psychiatry, 50(11), 1120-1128. doi:10.1016/j.jaac.2011.07.010
Substance Abuse and Mental Health Services Administration. (2013). Drug
Abuse Warning Network, 2011: National Estimates of Drug-Related
Emergency Department Visits. HHS Publication No. (SMA) 13-4760, DAWN
Series D-39. Rockville, MD: Substance Abuse and Mental Health Services
Administration.
Substance Abuse and Mental Health Services Administration. (2017). National
Survey of Substance Abuse Treatment Services (N-SSATS): 2016. Data on
Substance Abuse Treatment Facilities. BHSIS Series S-93, HHS Publication
No. (SMA) 17-5039. Rockville, MD: Substance Abuse and Mental Health
Administration.

PREDICTORS OF SHORT-TERM RESIDENTIAL

58

Substance Abuse and Mental Health Services Administration. (2018).
Treatments for substance use disorders. Retrieved from:
https://www.samhsa.gov/treatment/substance-use-disorders
United States Department of Health and Human Services (HHS), Office of the
Surgeon General. (2018). Facing Addiction in America: The Surgeon
General’s Spotlight on Opioids. Washington, DC: HHS.
Voshaar, R. C. O., Gorgels, W. J., Mol, A. J., van Balkom, A. J., Mulder, J., van
de Lisdonk, E. H.,. . . Zitman, F.G. (2006). Predictors of long-term
benzodiazepine abstinence in participants of a randomized controlled
benzodiazepine withdrawal program. Canadian Journal of Psychiatry, 51(7),
445-452. DOI: 10.1177/070674370605100706
White, W. L. (2014). Slaying the dragon: The history of addiction treatment and
recovery in America. Bloomington, IL: Chestnut Health Systems.
Williams, A. R., Barbieri, V., Mishlen, K., Levin, F. R., Nunes, E. V, Mariani, J. J.,
& Bisaga, A. (2017). Long-term follow-up study of community-based patients
receiving XR-NTX for opioid use disorders. The American Journal on
Addictions, 26(4), 319–325. https://doi.org/10.1111/ajad.12527
Young, R. M., Connor, J. P., & Feeney, G. F. X. (2011). Alcohol expectancy
changes over a 12-week cognitive-behavioral therapy program are predictive
of treatment success. Journal of Substance Abuse Treatment, 40, 18-25. doi:
10.1016/j.jsat.2010.08.003

PREDICTORS OF SHORT-TERM RESIDENTIAL

Appendix A
Table 1 – Demographics and Frequencies

59

PREDICTORS OF SHORT-TERM RESIDENTIAL
Table 1
Demographics and Frequencies
Combined
Sites
N = 1001
Age in Years (mean)
36.06
Detox LOS
5.37
(days, mean)
STR LOS
16.85
(days, mean)
Detox before STR?
744
(%)
(74.3%)
# of Prior Treatments
.16
(mean)
Age First Use, Years
24.35
(mean)
Male (%)
576 (58%)
STR Completion? (%)
538 (54%)
Race – White, Not
760
Hispanic
(76%)
Race – African
69 (7%)
American, Not
Hispanic
Race – American
7 (.7%)
Indian/Native
American
Race – Other
10 (1%)
Race – Bi-Racial
11 (1%)
Race – Latino,
133
Hispanic
(13%)
Race – Asian/Pacific
7
Islander
(.7%)
Route- Oral
439 (44%)
Route – IV Injection
457 (46%)
Route – Nasal
76 (8%)
Route – Smoking
22 (2%)
OOC – Heroin
514 (51%)
OOC – Stronger than
148
Morphine (MME)
(15%)
OOC – Equal to
314
Morphine (MME)
(31%)
OOC – Weaker than
24
Morphine (MME)
(2%)
a: Missing Data OOC: Opioid of Choice
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Site No. 1
N = 423

Site No. 2
N = 228

Site No. 3
N = 181

Site No. 4
N = 169

35.56
5.13

36.43
4.54

35.40
5.48

37.50
6.98

17.56

15.46

17.76

14.82

337
(79.7%)
.09

142
(64%)
.13

122
(67.4%)
.22

143
(84.6%)
.27

23.86

24.78

23.24

26.10

246 (52%)
222 (52%)
342
(81%)
27 (6%)

134 (59%)
142 (62%)
197
(86%)
14 (6.1%)

101 (56%)
92 (51%)
114
(63%)
8 (4%)

95 (56%)
82 (49%)
107
(63%)
20 (12%)

6 (1%)

1 (.4%)

0

3 (2%)

3 (.7%)
1 (.4%)
3 (2%)
3 (.7%)
1 (.4%)
2 (1%)
37
14
49
(8.7%)
(6%)
(27%)
5
0
1
(1%)
(.6%)
191 (45%) 123 (54%)
49 (27%)
190 (45%
79 (35%)
117 (65%)
32 (8%)
17 (8%)
8 (4%)
8 (1.9%)
6 (3%)
5 (3%)
214 (51%)
89 (39%)
127 (70%)
64
36
19
(15%)
(16%)
(10%)
138
99
32
(33%)
(43%)
(18%)
7
3
3
(1.7%)
(1.3%)
(2%)
STR: Short-term Residential

0
5 (3%)
33
(20%)
1
(.6%)
76 (45%)
71 (42%)
19 (11%)
3 (2%)
86 (51%)
29
(17%)
45
(27%)
11
(7%)
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Table 1 – continued
Demographics and Frequencies
Combined
Sites
N = 1001
Legal Classification –
544
Walk-in
(54%)
Legal Classification –
12
Parole
(1%)
Legal Classification –
60
Probation
(6%)
Legal Classification –
16
Legally Suggested
(2%)
Legal Classification –
4
Court Mandated
(.4%)
Marital Status –
104
Married
(10%)
Marital Status –
15
Widowed
(1%)
Veteran - Yes
10 (1%)
Veteran - No
991 (99%)
Unemployed
594 (59%)
Employed Full-time
42 (4%)
Employed Part-time
10 (1%)
Religion – Protestant
207 (21%)
Religion – Other
118 (12%)
Religion – Catholic
31 (3%)
Religion – Agnostic
10 (1%)
Religion – None
131 (13%)
Religion – Hindu
2 (.2%)
Religion – Atheist
1 (.1%)
Religion – Muslim
1 (.1%)
Religion – Universal
3 (.3%)
Payer –
777
State Sponsored
(78%)
Payer – Medicaid
64 (6%)
Payer – Commercial
68
Insurance
(7%)
Payer – Mental Health
45
Program
(4%)
Payer – Private Pay
13 (1%)
Reside –
182
Dallas/Ft. Worth Area
(18%)
Reside - Houston Area
220 (22%)
Reside - Austin Area
194 (19%)
Reside –
213
Northeast Texas
(21%)
Reside - Waco Area
115 (11%)
Reside – San
53
Antonio/South Texas
(5%)
Reside - North & West
15
Texas
(1%)
Reside - Outside Texas
9 (1%)
a: Missing Data OOC: Opioid of Choice

Site No. 1
N = 423

Site No. 2
N = 228
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Site No. 3
N = 181

344
147
13
(81%)
(64%)
(7%)
8
3
0
(1.9%)
(1%)
41
9
5
(10%)
(4%)
(3%)
2
12
1
(.5%)
(5%)
(.6%)
1
1
2
(.2%)
(.4%)
(1%)
53
45
1
(13%)
(20%)
(.6%)
9
3
1
(2%)
(1%)
(.6%)
4 (1%)
2(.9%)
1(.6%)
419 (99%) 226 (99%)
180 (99%)
371 (88%) 158 (69%)
21 (12%)
21 (2%)
20 (9%)
a
6 (1%)
3 (1%)
a
80 (8%)
58 (25%)
30 (17%)
28 (7%)
25 (11%)
30 (17%)
5 (2%)
6 (3%)
9 (5%)
1 (.2%)
8 (4%)
1 (.6%)
19 (4%)
20 (9%)
64 (35%)
1 (.2%)
0
0
1 (.2%)
0
0
0
1 (.4%)
0
0
2 (.9%)
1 (.6%)
339
174
126
(80%)
(76%)
(70%)
20 (5%)
17 (8%)
15 (8%)
30
17
7
(3%)
(8%)
(4%)
20
7
17
(5%)
(3%)
(9%)
5 (2%)
3 (1%)
5 (3%)
104
55
13
(25%)
(24%)
(7%)
35 (8%)
17 (8%)
14 (8%)
89 (21%)
8 (4%)
94 (52%)
67
140
3
(16%)
(61%)
(2%)
95 (22%)
4 (2%)
11 (6%)
17
0
33
(4%)
(18%)
14
1
5
(3%)
(.4%)
(3%)
2 (.4%)
3 (1%)
3 (2%)
STR: Short-term Residential

Site No. 4
N = 169
40
(24%)
1
(.6%)
5
(3%)
1
(.6%)
0
5
(3%)
2
(1%)
3 (2%)
166 (98%)
44 (26%)
1 (.6%)
1(.6%)
39 (23%)
35 (21%)
11 (7%)
0
28 (17%)
1 (.6%)
0
0
0
138
(82%)
12 (7%)
14
(8%)
1
(.6%)
0
3
(2%)
154 (91%)
3 (2%)
3
(2%)
1 (.6%)
3
(2%)
1
(.6%)
1 (.6%)
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Table 2
Mann-Whitney U Results
Mann-Whitney U for
STR Completion
Combined Sites
Age in Years
121820.500
Age First Use
113742.000
Detox LOS
113005.000
# of Prior Detox or STR
119457.500
Frequency Last 30 Days
108208.500
LOS: Length of Stay STR: Short-term Residential

Sig.

Mann-Whitney U for
Detox Prior to STR

Sig.

.550
.286
.010
.060
.005

92107.500
86139.000
514.000
94714.000
56879.500

.381
.254
<.001
.737
<.001

PREDICTORS OF SHORT-TERM RESIDENTIAL

Appendix C
Table 3 – Pearson Chi-Square Crosstabulations

64

PREDICTORS OF SHORT-TERM RESIDENTIAL
Table 3
Pearson Chi-Square Crosstabulations
Pearson Chi-Square
with STR Completion
Combined Sites
Treatment Location
9.428
Gender
11.483
Race
.669
Opioid of Choice
8.268
Route
8.606
Legal Classification
4.868
Marital Status
4.163
Veteran Status
1.073
Employment Status
8.482
Religion
7.381
Payer Type
6.843
Geographic Region
10.579
Detox: Detoxification STR: Short-term Residential
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Sig.

Pearson Chi-Square with
Detox Prior to STR

Sig.

.024
.001
.995
.041
.035
.301
.384
.300
.014
.496
.233
.158

37.585
.178
4.424
10.767
6.831
13.118
7.591
1.086
1.111
8.291
47.063
16.035

<.001
.673
.619
.013
.077
.011
.108
.297
.574
.406
<.001
.025
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Appendix D
Table 4 – Binomial Logistic Regression Results – Demographic and
Drug Use History: Combined Treatment Sites
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Table 4
Binomial Logistic Regression Results –
Demographic and Drug Use History: Combined Treatment Sites
Odds
Sig.
95%
Adjusted
Ratio
Confidence
Odds
Interval
Ratio
Treatment Location
Site 1 (Index)
.025
Site 2 1.495 .017
[1.076, 2.077]
1.497
Site 3 .936
.709
[.661, 1.326]
.337
Site 4 .853
.384
[.597, 1.219]
1.573
Gender (Male)
1.546 .001
[1.201. 1.989]
1.689
Age in Years
1.005 .496
[.991, 1.018]
1.009
Opioid of Choice
Heroin (Index)
.046
Stronger than Morphine .928
.691
[.644, 1.339]
1.078
(MME)
Equal to Morphine 1.296 .073
[.976, 1.721]
1.527
(MME)
Weaker than Morphine .452
.072
[.190, 1.074]
.380
(MME)
Frequency Last 30
.986
.021
[.974, .998]
.984
Days
Number of Prior
.861
.236
[.672, 1.103]
.741
Treatments
Route
IV Injection (Index)
.037
Oral 1.246 .101
[.958, 1.620]
.826
Nasal 2.031 .007
[1.217, 3.391]
2.342
Smoking .996
.992
[.423, 2.343]
.931
Employment
Unemployed (Index)
.019
Employed Full-time 2.815 .005
[1.359, 5.831]
2.132
Employed Part-time 1.320 .670
[.369, 4.724]
1.383
STR: Short-term Residential
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Sig.

95%
Confidence
Interval

.016
.041
.042
.185
.002
.336

[1.016, 2.206]
[.118, .962]
[.806, 3.070]
[1.280, 3.989]
[.991, 1.028]

.153
.862

[.464, 2.504]

.361

[616, 3.784]]

.241

[.075, 1.918]

.051

[.969, 1.000]

.155

[.490, 1.120]

.124
.664
.022
.912

[.349, 1.956]
[1.129, 4.856]
[.261, 3.316]

.135
.049
.660

[1.002, 4.538]
[.991, 1.028]
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Appendix E
Table 5 – Binomial Logistic Regressions for STR Completion –
Detoxification as Main Predictors
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Appendix F
Proposal Application – The Committee for the Protection Of Human Subjects at
The University of Texas Health Science Center at Houston
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Appendix G
Proposal Acceptance Letter - The Committee for the Protection Of Human
Subjects at the University of Texas Health Science Center at Houston
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